A COVID-19 treatment used by President Trump during his illness was tested using a cell line derived from a human fetus, even though his administration opposes the use of aborted fetuses for scientific purposes.
Regeneron’s antibody cocktail, touted by Trump as a “cure” for COVID-19, was tested using a cell line originally derived from human embryonic kidney cells from an abortion performed in the Netherlands in the 1970s.
The cell line was used to test whether the antibody cocktail could neutralize the coronavirus. The cells are considered “immortalized,” meaning they divide indefinitely.
However, fetal tissue was not used in research for the antibody cocktail, and neither human stem cells nor human embryonic stem cells were used in development, a Regeneron spokesperson said in a statement.
The Trump administration last year banned the National Institutes of Health from using fetal tissue in research and said outside proposals funded by the agency must undergo an ethics review.
The cell line derived from the aborted fetus is a common and widespread tool in research labs and is old enough that it is not prohibited under the Trump administration’s rules.
Anti-abortion groups, which pushed the Trump administration to end the use of fetal tissue in research, also have not expressed concern about the use of the cell line.
The Charlotte Lozier Institute, an anti-abortion research group, said in a statement it had reviewed the published information about Regeneron and didn’t take issue with it.
……..
- Discussion
-
COVID-19 treatment touted by Trump was tested with cells drawn from fetal tissue https://t.co/e6aMpiuRwO pic.twitter.com/0o6a6mDlqE
— The Hill (@thehill) October 8, 2020
Coming to your local cable at 3 am https://t.co/TcHARLL2Q0
— Tom Nichols (@RadioFreeTom) October 8, 2020
You must be logged in to reply to this topic.